# Diagnostic Accuracy of Raman Spectroscopy for Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis

**Authors:** Xiting Xiang, Xing Li, Zhihui Zhu, Qing Sun, Nuo Hu, Tao Zhang

PMC · DOI: 10.3390/diagnostics16050648 · Diagnostics · 2026-02-24

## TL;DR

This study reviews how well Raman spectroscopy can detect oral potentially malignant disorders and differentiate them from normal tissue and cancer.

## Contribution

A systematic review and meta-analysis of Raman spectroscopy's diagnostic accuracy for oral potentially malignant disorders.

## Key findings

- Raman spectroscopy showed high pooled sensitivity (0.84) and specificity (0.90) for distinguishing OPMDs from normal tissue.
- It also demonstrated strong accuracy (AUC of 0.94) in differentiating OPMDs from oral squamous cell carcinoma.
- Micro-Raman had higher sensitivity, while fiber-Raman had better specificity in subgroup analyses.

## Abstract

Objective: The aim of this study was to summarize the accuracy and efficacy of Raman spectroscopy (RS) technology in identifying Oral Potentially Malignant Disorders (OPMDs). Methods: This systematic review was registered in PROSPERO (CRD420251124866). A literature search was conducted in databases including PubMed, Embase, and Web of Science from inception up to September 2025. The risk of bias of included studies was evaluated using the QUADAS-2 tool. Appropriate statistical techniques were applied to perform heterogeneity analysis, subgroup analyses, and calculation of pooled diagnostic efficacy indices. Results: A total of 12 studies involving 2810 samples were included. In the “OPMDs vs. Normal” group, RS achieved a pooled sensitivity of 0.84 (95% CI: 0.78–0.88), specificity of 0.90 (95% CI: 0.73–0.97), and AUC of 0.89 (95% CI: 0.86–0.91). In the “OPMDs vs. Oral squamous cell carcinoma (OSCC)” group, the pooled sensitivity was 0.89 (95% CI: 0.82–0.94), specificity was 0.91 (95% CI: 0.85–0.95), and AUC was 0.94 (95% CI: 0.91–0.96). Heterogeneity analysis revealed low heterogeneity in the “OPMDs vs. OSCC” group (I2 = 22.8%) and moderate heterogeneity in the “OPMDs vs. Normal oral mucosa” group (I2 = 58.9%). Subgroup analyses were performed: sample type exerted no significant impact on heterogeneity (p > 0.19), while Raman type (micro vs. fiber) showed potential to modulate diagnostic efficacy, micro-Raman had higher sensitivity (0.916 vs. 0.811), and fiber-Raman had better specificity (0.917 vs. 0.843). No significant publication bias was observed (Egger’s p > 0.3). Conclusions: Raman spectroscopy is an effective and reliable tool for screening and differentiating OPMDs.

## Linked entities

- **Diseases:** Oral squamous cell carcinoma (MONDO:0004958)

## Full-text entities

- **Diseases:** OSCC (MESH:D000077195), OPMDs (MESH:C537245)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984992/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984992/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984992/full.md

---
Source: https://tomesphere.com/paper/PMC12984992